CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Jun. 30, 2025	Jun. 30, 2024
Operating activities
Net income	$ 2,281	$ 5,102
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	12,880	12,769
Amortization of deferred financing costs charged to interest expense	1,309	1,437
Stock-based compensation expense	1,284	2,290
Deferred income taxes, net	1,437	(311)
Changes in operating assets and liabilities:
Accounts receivable	4,933	778
Other assets	(4,216)	2,484
Accounts payable and accrued liabilities	(11,614)	(6,515)
Accrued payroll	2,175	437
Other liabilities	2,067	(3,540)
Net cash provided by operating activities	12,536	14,931
Investing activities
Purchase of equipment and improvements	(213)	(627)
Net cash used in investing activities	(213)	(627)
Financing activities
Proceeds from revolving line of credit	172,056	257,067
Repayment of revolving line of credit	(170,075)	(252,123)
Repayments of debt obligations	(14,250)	(17,813)
Payments of deferred financing costs	(202)	0
Proceeds from issuance of common stock upon exercise of options and warrants	0	261
Payment of tax obligations resulting from net exercise of stock options	0	(1,488)
Net cash used in financing activities	(12,471)	(14,096)
Net change in cash	(148)	208
Cash - beginning of period	342	215
Cash - end of period	194	423
Supplemental disclosure of cash flow information
Cash paid during the period for interest	10,415	11,656
Cash paid during the period for income taxes	563	2,280
Common stock surrendered for the exercise of stock options	0	2,432
Lease liability recognized to acquire a right-of-use asset	$ 4,187	$ 0